Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100,554 | 85,873 | 22,938 | 30,226 | 21,970 |
| Marketable Securities | 61,959 | 17,239 | 235,837 | 49,773 | 77,725 |
| Receivables | 815 | 568 | 1,763 | 1,186 | 2,608 |
| TOTAL | $169,684 | $109,167 | $264,650 | $85,552 | $106,047 |
| Non-Current Assets | |||||
| PPE Net | 58,754 | 65,087 | 70,829 | 78,192 | 85,265 |
| Investments And Advances | 0 | 55,686 | 0 | 0 | 0 |
| Intangibles | 25,798 | 25,798 | 25,798 | 25,798 | 26,438 |
| Other Non-Current Assets | 3,525 | 5,770 | 8,019 | 724 | 964 |
| TOTAL | $88,077 | $152,341 | $104,646 | $104,714 | $112,667 |
| Total Assets | $257,761 | $261,508 | $369,296 | $190,266 | $218,714 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 38,482 | 963 | 880 | 816 | 4,751 |
| Accounts payable and accrued liabilities | 5,919 | 7,926 | 7,344 | 6,513 | 6,883 |
| Accrued Expenses | 5,611 | 6,615 | 9,093 | 7,325 | 6,787 |
| TOTAL | $50,954 | $21,176 | $35,347 | $45,966 | $57,463 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,482 | 29,529 | 30,493 | 31,372 | 32,189 |
| Deferred Revenues | 942 | 5,672 | 18,030 | 31,312 | 39,042 |
| Other Non-Current Liabilities | 616 | 764 | 31,030 | 739 | 720 |
| TOTAL | $43,310 | $44,505 | $77,649 | $58,799 | $75,449 |
| Total Liabilities | $94,264 | $65,681 | $112,996 | $104,765 | $132,912 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,098 | 19,624 | 19,548 | 11,144 | 9,226 |
| Common Shares | 176 | 137 | 137 | 78 | 64 |
| Retained earnings | -570,175 | -487,395 | -410,535 | -351,741 | -297,430 |
| Other shareholders' equity | -378 | 10,247 | -4 | -16 | -54 |
| TOTAL | $163,497 | $195,827 | $256,300 | $85,501 | $85,802 |
| Total Liabilities And Equity | $257,761 | $261,508 | $369,296 | $190,266 | $218,714 |